The global cell and gene therapy clinical trials market, valued at USD 10.72 billion in 2024, is projected to grow at a CAGR of 15.4% from 2025 to 2034, reaching an estimated USD 44.83 billion by 2034. The surge is driven by an expanding pipeline of gene-modified cell therapies, rapid progress in personalized medicine, and strong investment from both...